(Q47972546)

7 February 2018

title

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome (English)

1 reference

7 February 2018

0 references

7

1 reference

7 February 2018

author name string

Samir K Ballas

1

1 reference

7 February 2018

Beatrice Files

2

1 reference

7 February 2018

Lori Luchtman-Jones

3

1 reference

7 February 2018

Lennette Benjamin

4

1 reference

7 February 2018

Paul Swerdlow

5

1 reference

7 February 2018

Lee Hilliard

6

1 reference

7 February 2018

Miguel Abboud

8

1 reference

7 February 2018

Slawomir Wojtowicz-Praga

9

1 reference

7 February 2018

J Michael Grindel

10

1 reference

7 February 2018

publication date

1 May 2004

1 reference

7 February 2018

published in

Hemoglobin

1 reference

7 February 2018

volume

28

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

85-102

1 reference

7 February 2018

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

cites work

1 reference

https://api.crossref.org/works/10.1081%2FHEM-120035919

Randomized, controlled trial of RheothRx (poloxamer 188) in patients with suspected acute myocardial infarction. RheothRx in Myocardial Infarction Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FHEM-120035919

Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FHEM-120035919

Acute chest syndrome in children with sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FHEM-120035919

Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FHEM-120035919

Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FHEM-120035919

Rib infarcts and acute chest syndrome in sickle cell diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FHEM-120035919

Acute chest syndrome in sickle cell disease: CT evidence of microvascular occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FHEM-120035919

Effect of transfusion in acute chest syndrome of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FHEM-120035919

Determination of hemoglobin saturation in patients with acute sickle chest syndrome: a comparison of arterial blood gases and pulse oximetry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FHEM-120035919

Peak expiratory flow rate and the acute chest syndrome in homozygous sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FHEM-120035919

Pulmonary function in sickle cell disease with or without acute chest syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FHEM-120035919

21 January 2018

Identifiers

DOI

10.1081/HEM-120035919

1 reference

7 February 2018

1 reference

7 February 2018